Difference between revisions of "Part:BBa K3034000"
| Line 2: | Line 2: | ||
<partinfo>BBa_K3034000 short</partinfo> | <partinfo>BBa_K3034000 short</partinfo> | ||
| − | CrpP is a novel ciprofloxacin-modifying enzyme which can phosphorylate ciprofloxacin(CIP).Then the phosphorylated CIP goes through multiple steps of degradation spontaneously and produces 1,4-dihydroquinoline finally[1]. 1,4-dihydroquinoline is used as a kind of new carriers for specific brain delivery [2], so we can infer that it's nontoxic. This part is responsible for degradation of ciprofloxacin in our project. | + | CrpP is a novel ciprofloxacin-modifying enzyme which can phosphorylate ciprofloxacin(CIP). Then the phosphorylated CIP goes through multiple steps of degradation spontaneously and produces 1,4-dihydroquinoline finally[1]. 1,4-dihydroquinoline is used as a kind of new carriers for specific brain delivery [2], so we can infer that it's nontoxic. This part is responsible for degradation of ciprofloxacin in our project. |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
| Line 16: | Line 16: | ||
This gene codes for a protein of 65 amino acids with a molecular mass about 15 kDa. | This gene codes for a protein of 65 amino acids with a molecular mass about 15 kDa. | ||
| + | ===Expression of CrpP-Histag=== | ||
| + | Expression of CrpP-Histag is unsatisfying in E.coli DH5α, so we clone pelB-5D, CrpP and 6×Histag CDS into an expression vector, then the vector is transformed into E.coli BL21(DE3). We use IPTG to induce its overexpression and SDS-PAGE is used to detect target protein's expression. | ||
| + | [[File:SDS-PAGE of CrpP-Histag.png|500px|thumb|center|'''Fig. 1'''SDS-PAGE of CrpP-Histag. Lane 1: Protein ladder; Lane 2、3、5 and 6: experimental group(0.5mM IPTG is added); Lane 3、4、7 and 8: control group(without 0.5mM IPTG)]] | ||
===Enzyme activity of CrpP=== | ===Enzyme activity of CrpP=== | ||
Revision as of 15:19, 11 October 2019
CrpP：Ciprofloxacin-Modifying Enzyme
CrpP is a novel ciprofloxacin-modifying enzyme which can phosphorylate ciprofloxacin(CIP). Then the phosphorylated CIP goes through multiple steps of degradation spontaneously and produces 1,4-dihydroquinoline finally[1]. 1,4-dihydroquinoline is used as a kind of new carriers for specific brain delivery [2], so we can infer that it's nontoxic. This part is responsible for degradation of ciprofloxacin in our project.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Contents
Characterization
Molecular weight
This gene codes for a protein of 65 amino acids with a molecular mass about 15 kDa.
Expression of CrpP-Histag
Expression of CrpP-Histag is unsatisfying in E.coli DH5α, so we clone pelB-5D, CrpP and 6×Histag CDS into an expression vector, then the vector is transformed into E.coli BL21(DE3). We use IPTG to induce its overexpression and SDS-PAGE is used to detect target protein's expression.
Enzyme activity of CrpP
References
[1]Chávez-Jacobo, Víctor M., et al. "CrpP is a novel ciprofloxacin-modifying enzyme encoded by the Pseudomonas aeruginosa pUM505 plasmid." Antimicrobial agents and chemotherapy 62.6 (2018): e02629-17. [2]Foucout, Léna?g, et al. "Synthesis, radiosynthesis and biological evaluation of 1, 4-dihydroquinoline derivatives as new carriers for specific brain delivery." Organic & biomolecular chemistry 7.18 (2009): 3666-3673.